2023-02-18T18:27:56-07:00 2022-12-31 990EZ 2022-01-01 475146231 SMARTHEALTH ACTIVATOR NFP SMAR 741 Congressional Lane Riverwoods IL 60015 Jeanne Prete Executive Director / Secretary 8576304517 2023-02-17 1 1 11 0 AAL2 2022 2023-03-07 01:45:13Z X X X X 6500 X 6500 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6500 5000 0 0 266 0 0 0 5266 1234 1425 0 2659 1425 2659 0 0 0 0 1425 2659 0 0 1425 2659 X SmartHealth Activator (SHA) identifies and advance extraordinary biotechnology being developed at Midwest Universities. The problem we solve is that there are brilliant scientist at Midwest Universities who are developing life-saving biotechnology, but the scientist is simply not equipped to commercialize their research. SHA provides a number of solutions for scientist building technology transfer, corporate creation, IP protection, fundraising, and branding, but most importantly we build operation teams around the scientist. The OPS Team is comprised of elites in biotech who have the experience, expertise, and passion to facilitate the commercialization of life-saving biotechnology being develped at Midwest Universities. See Schedule o - Paid Grant to Biotech Startup- Grant issued for startup. Cadenza Bio's mission is focused on development of novel therapeutic drugs for treatment of demyelinating, inflammatory, and neurodegenerative diseases. 0 5000 See Schedule o -Independent Contractors - SmartHealth Activator contracted help from various professionals to assist in growth and goals. 0 266 5266 Tom Denison President 40 0 0 0 Gary Winer Board Director 10 0 0 0 Teddy Scott Board Director 10 0 0 0 Jeanne Prete Secretary 10 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Tom Denison 741 Congressional Lane Riverwoods IL 60015 7736109643 0 0 0 0 0 0 0 0 0 0 0 NONE NONE 1 X 5097 6000 6000 6000 6500 29597 0 0 0 0 0 0 0 0 0 0 0 0 5097 6000 6000 6000 6500 29597 29597 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 29597 1 1 X Form 990-EZ, Part I, Line 10 Cadenza Bio - Grant issued for startup. Cadenza Bio's mission is focused on development of novel therapeutic drugs for treatment of demyelinating, inflammatory, and neurodegenerative diseases Form 990-EZ, Part III, Line (28-31) SmartHealth Activator (SHA) identifies and advance extraordinary biotechnology being developed at Midwest Universities. The problem we solve is that there are brilliant scientist at Midwest Universities who are developing life-saving biotechnology, but the scientist is simply not equipped to commercialize their research. SHA provides a number of solutions for scientist building technology transfer, corporate creation, IP protection, fundraising, and branding, but most importantly we build operation teams around the scientist. The OPS Team is comprised of elites in biotech who have the experience, expertise, and passion to facilitate the commercialization of life-saving biotechnology being developed at Midwest Universities. See Schedule o - Paid Grant to Biotech Startup- Grant issued for startup. Cadenza Bio's mission is focused on development of novel therapeutic drugs for treatment of demyelinating, inflammatory, and neurodegenerative diseases. See Schedule o -Independent Contractors - SmartHealth Activator contracted help from various professionals to assist in growth and goals.